Senior Scientist 1BioMarin PharmaceuticalNovato, California, United States
OC 30.2 - Stable Factor VIII Expression and Improvement in Bleeding Phenotype Following Early Childhood Treatment with Adeno-Associated Viral Gene Therapy in the Severe Hemophilia A Dog Model
Monday, June 26, 202311:00 – 11:15 ET
